Anmelden
Cover von Business Of Biotech

Wirtschaft

Business Of Biotech

von Ben Comer

Website RSS

Folgenzu den neuesten

  1. Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Thijs Spoor, CEO at Perspective Therapeutics, a company developing Pb 212 (lead)-bas

  2. Investing In Early-Stage Oncology With Yosemite's Dan McHugh

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Dan McHugh, head of the investment team at Yosemite, explains the San Francisco VC g

  3. Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech we're speaking with Alan Bash, President, Carvykti, at Legend Biotech, about how Carv

  4. Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech we speak with Dr. Marc Hedrick, M.D., President and CEO at Plus Therapeutics, about t

  5. Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech we speak with Rahul Aras, Ph.D., President and CEO at Iterion Therapeutics, about cap

  6. Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, we're speaking with Thomas von Erlach, Ph.D., Cofounder and CEO at Vivtex, a company

  7. An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech we speak with Monika Sumra, Ph.D., about how leadership, culture, and performance eme

  8. Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Jared Bauer, Cofounder and CEO at Seek Labs, talks about his adventures in company t

  9. Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, we're speaking with Cindy Perettie, Executive Vice President and Global Head at Kite

  10. BoB@JPM: Brian Hilberdink, Boehringer Ingelheim

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Brian Hilberdink, President of U.S. Human Pharma at Boehringer Ingelheim, returns to

  11. BoB@JPM: Ron Cooper, enGene

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech -- on location at the J.P. Morgan Healthcare Conference -- we're speaking with Ron Co

  12. BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) The Business of Biotech was back in San Francisco for the J.P. Morgan Healthcare Conference (January 12 - 15) and this week we sit down

  13. A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, we're speaking with Kenneth Galbraith, CEO and Board Chair at Zymeworks, a biotech d

  14. Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) This week's special holiday episode of the Business of Biotech brings seven chief editors from the Life Science Connect family together

  15. Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks about his experiences building cell t

  16. Modernizing Clinical Trial Operations With Merck's Jennifer Sheller

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Jennifer Sheller, SVP and Head of Global Clinical Trial Operations at Merck talks ab

  17. Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Bruce Culleton, M.D., CEO at ProKidney, talks about moving from academic research to

  18. Engineering B Cells With Immusoft's Sean Ainsworth

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Sean Ainsworth, CEO and Chairman at Immusoft, talks about transitioning from the res

  19. Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Dan Schmitt, President and CEO at Actuate Therapeutics, talks about building a compa

  20. Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Cyril Konto, M.D., president, executive director, and CEO at Ichnos Glenmark Innovation (IGI) talks about the p

  21. Biotech Funding And IPO Temperature Check With Create Medicine's Allan Shaw

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) Allan Shaw, Chief Financial Officer and Chief Business Officer at Create Medicines, is back on the Business of Biotech this week, with

  22. Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Mardi Dier, CFO at Madrigal Pharmaceuticals, talks about building relationships in i

  23. Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, we're speaking with Bernard Ravina, M.D., CEO at Vima Therapeutics, a company that e

  24. BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode — the last of our four-part series focused on South Florida — we catch up with Rich Daly, CEO at Catalyst Pharma

  25. BoB In South Florida: Anthony Japour, M.D., iTolerance

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech -- part three in a four part series recorded in-person at Catalyst Pharmaceuticals' M

  26. BoB In South Florida: Daniel Teper, NAYA Therapeutics

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) In this week's episode of the Business of Biotech -- part two in a four-part series recorded in-person at Catalyst Pharmaceuticals' Mia

  27. BoB In South Florida: Raquel Cabo, Miami Biotech Collective

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) The Business of Biotech is on location in Miami this week! For the first episode in this four-part series on the biotech scene in South

  28. The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Rob Abbott, CEO of ISPOR, explains how startup and early-stage clinical drug develop

  29. Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Joel Latham, President and CEO at Incannex Healthcare, talks about developing cannabinoid and psychedelic combi

  30. Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode, Lyle Small, Founder and CEO at Lahjavida, a dye drug conjugate start-up, talks about creating the famous color-

Ältere Folgen

Anmelden oder registrieren

Jetzt

0:00 / 0:00